GE accepts $1B bid for health IT assets, reaffirms focus on diagnostics, AI

Selling the units will leave GE with a more focused but still substantial healthcare business. (GE Healthcare)

GE Healthcare is offloading health IT assets to private equity group Veritas Capital for $1.05 billion in cash. The sale of the value-based care unit narrows GE’s focus to the diagnostic imaging and mobile monitoring businesses that generate most of its medtech sales.

The takeover will give Veritas control of GE’s assets for managing health finances, workforces and ambulatory care. Veritas, which lists Truven Health Analytics and Verscend Technologies among its health IT investments, will turn the acquired units into a standalone company. GE is now working with Veritas on the transition of the U.S. and Indian sites and staff that make up the business units.

Selling the units will leave GE with a more focused but still substantial healthcare business. GE groups the units in its IT and digital solutions business, which pulls in around $2 billion a year. Some of the units responsible for those sales will remain with GE after the deal closes in the third quarter.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The remaining IT businesses will sit alongside imaging, mobile diagnostics and monitoring and life sciences in the slimmed-down organization. GE’s imaging and mobile units generate about $12 billion a year and remain a big part of the company’s plans. 

“GE Healthcare will continue to significantly invest in core digital solutions, such as smart diagnostics, connected devices, AI and enterprise imaging, that will drive precision health for our customers,” GE Healthcare CEO Kieran Murphy said in a statement. “We will continue to lead in data analytics, command centers, advanced visualization and image management tools to create better customer and patient outcomes.”

The sale of the health IT assets is an early manifestation of John Flannery’s vision for GE. Flannery, a former CEO of GE Healthcare, took over the broader business last year and promptly outlined plans to sell $20 billion worth of businesses. The selloff strategy reflects Flannery’s belief that GE’s problems stem from the complexity of the company.

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its Star Trek-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.